NCT01570751 - A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin | Biotech Hunter

Enrollment

145

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec

Cross-over trial, part 1: Individually adjusted IDeg administered subcutaneously (s.c., under the skin) once daily for 16 weeks in each treatment period.

DRUG

insulin glargine

Cross-over trial, part 2: Individually adjusted IGlar administered subcutaneously (s.c., under the skin) once daily for the 16 week run-in period followed by 16 weeks in each treatment period.

Trial Locations (46)

10301

Novo Nordisk Investigational Site, Staten Island

11768

Novo Nordisk Investigational Site, Northport

12206

Novo Nordisk Investigational Site, Albany

19107

Novo Nordisk Investigational Site, Philadelphia

20852

Novo Nordisk Investigational Site, Rockville

27834

Novo Nordisk Investigational Site, Greenville

30076

Novo Nordisk Investigational Site, Roswell

32207

Novo Nordisk Investigational Site, Jacksonville

33012

Novo Nordisk Investigational Site, Hialeah

33016

Novo Nordisk Investigational Site, Miami Lakes

33030

Novo Nordisk Investigational Site, Homestead

33155

Novo Nordisk Investigational Site, Miami

33156

Novo Nordisk Investigational Site, Miami

33709

Novo Nordisk Investigational Site, St. Petersburg

34201

Novo Nordisk Investigational Site, Bradenton

34741

Novo Nordisk Investigational Site, Kissimmee

37212

Novo Nordisk Investigational Site, Nashville

37411

Novo Nordisk Investigational Site, Chattanooga

37660

Novo Nordisk Investigational Site, Kingsport

40502

Novo Nordisk Investigational Site, Lexington

42431

Novo Nordisk Investigational Site, Madisonville

45005

Novo Nordisk Investigational Site, Franklin

45429

Novo Nordisk Investigational Site, Kettering

46123

Novo Nordisk Investigational Site, Avon

53209

Novo Nordisk Investigational Site, Milwaukee

60611

Novo Nordisk Investigational Site, Chicago

65109

Novo Nordisk Investigational Site, Jefferson City

70002

Novo Nordisk Investigational Site, Metairie

75218

Novo Nordisk Investigational Site, Dallas

75230

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

77478

Novo Nordisk Investigational Site, Sugar Land

78154

Novo Nordisk Investigational Site, Schertz

78207

Novo Nordisk Investigational Site, San Antonio

85206

Novo Nordisk Investigational Site, Mesa

89106

Novo Nordisk Investigational Site, Las Vegas

93720

Novo Nordisk Investigational Site, Fresno

94583

Novo Nordisk Investigational Site, San Ramon

94904

Novo Nordisk Investigational Site, Greenbrae

98405

Novo Nordisk Investigational Site, Tacoma

70461-4231

Novo Nordisk Investigational Site, Slidell

01655

Novo Nordisk Investigational Site, Worcester

48034-7661

Novo Nordisk Investigational Site, Southfield

08648

Novo Nordisk Investigational Site, Lawrenceville

78363-6322

Novo Nordisk Investigational Site, Kingsville

00674

Novo Nordisk Investigational Site, Manatí